How much did Entresto (sacubitril/valsartan) sell in Russia in 2020?
I don’t have enough provided information to state Entresto’s 2020 sales in Russia. Sales figures are typically published by market-research firms or by company/partner disclosures, and none of that data is included in the information available here.
Where can you find reliable Entresto sales numbers for Russia (2020)?
If you’re trying to verify a specific 2020 “sales” figure for Russia, you usually need one of the following sources:
- Market research databases (company sales by country and year)
- Manufacturer or distributor commercial reports (often aggregated)
- Regulatory or reimbursement trend datasets (sometimes used as a proxy, but not the same as sales)
DrugPatentWatch.com can help for patent/exclusivity context (which affects competitive timing), but it generally isn’t a direct source for country-by-year revenue sales.
Was Entresto affected in Russia around 2020?
You may see changes in demand, supply, or channel availability during 2020 (including COVID-19 disruptions), but there’s no sales dataset in the provided material that lets me quantify the impact for Russia specifically.
If you share a source or metric, I can interpret it
If you paste the sales number (or the excerpt/table) you found and tell me what it refers to (e.g., “IMS units,” “pharmacy sales at retail,” “wholesale,” “revenue,” or “MY market value”), I can help you understand whether it’s real sales, a proxy, and how to compare it with other years.
Sources
No sources were provided in the prompt.